Magnus Financial Group LLC Acquires 104 Shares of iShares Biotechnology ETF (NASDAQ:IBB)

Magnus Financial Group LLC boosted its holdings in shares of iShares Biotechnology ETF (NASDAQ:IBB) by 0.8% during the 4th quarter, HoldingsChannel reports. The institutional investor owned 12,967 shares of the financial services provider’s stock after buying an additional 104 shares during the period. Magnus Financial Group LLC’s holdings in iShares Biotechnology ETF were worth $1,714,000 as of its most recent SEC filing.

Several other institutional investors also recently bought and sold shares of IBB. Security National Bank of SO Dak increased its position in iShares Biotechnology ETF by 0.7% during the second quarter. Security National Bank of SO Dak now owns 10,461 shares of the financial services provider’s stock worth $1,436,000 after acquiring an additional 75 shares during the period. SPC Financial Inc. lifted its stake in iShares Biotechnology ETF by 2.4% during the third quarter. SPC Financial Inc. now owns 3,265 shares of the financial services provider’s stock worth $475,000 after purchasing an additional 75 shares during the period. Werba Rubin Papier Wealth Management boosted its stake in iShares Biotechnology ETF by 2.7% in the 3rd quarter. Werba Rubin Papier Wealth Management now owns 2,918 shares of the financial services provider’s stock valued at $425,000 after buying an additional 76 shares in the last quarter. Capital Investment Advisors LLC boosted its stake in shares of iShares Biotechnology ETF by 1.0% in the 4th quarter. Capital Investment Advisors LLC now owns 10,449 shares of the financial services provider’s stock valued at $1,381,000 after purchasing an additional 99 shares in the last quarter. Finally, Prairie Wealth Advisors Inc. boosted its position in iShares Biotechnology ETF by 6.0% in the second quarter. Prairie Wealth Advisors Inc. now owns 1,765 shares of the financial services provider’s stock valued at $242,000 after buying an additional 100 shares in the last quarter. 62.45% of the stock is currently owned by institutional investors.

iShares Biotechnology ETF Stock Performance

NASDAQ IBB opened at $136.07 on Wednesday. The stock’s 50 day simple moving average is $136.15 and its 200 day simple moving average is $141.84. iShares Biotechnology ETF has a one year low of $123.60 and a one year high of $150.57.

iShares Biotechnology ETF Cuts Dividend

The firm also recently announced a dividend, which was paid on Friday, December 20th. Stockholders of record on Tuesday, December 17th were paid a $0.0624 dividend. The ex-dividend date of this dividend was Tuesday, December 17th.

About iShares Biotechnology ETF

iShares Nasdaq Biotechnology ETF (the Fund), formerly iShares Nasdaq Biotechnology Index Fund, is an exchange-traded fund (ETF). The Fund seeks investment results that correspond generally to the price and yield performance of the NASDAQ Biotechnology Index (the Index). The Index contains securities of NASDAQ listed companies that are classified according to the Industry Classification Benchmark as either biotechnology or pharmaceuticals, which also meet other eligibility criteria determined by NASDAQ.